Ian Sacks - 15 Jul 2021 Form 4 Insider Report for HEALTHEQUITY, INC. (HQY)

Role
Director
Signature
/s/ Delano W. Ladd, attorney-in-fact
Issuer symbol
HQY
Transactions as of
15 Jul 2021
Net transactions value
-$764,904
Form type
4
Filing time
19 Jul 2021, 12:10:36 UTC
Next filing
29 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HQY Common Stock Sale $486,783 -6,390 -4.1% $76.18 149,656 15 Jul 2021 Direct F1
transaction HQY Common Stock Sale $278,122 -3,610 -2.4% $77.04 146,046 15 Jul 2021 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HQY Stock Option (right to buy) 15,000 15 Jul 2021 Common Stock 15,000 $21.27 Direct F3
holding HQY Stock Option (right to buy) 15,000 15 Jul 2021 Common Stock 15,000 $14.00 Direct F3
holding HQY Stock Option (right to buy) 15,000 15 Jul 2021 Common Stock 15,000 $25.39 Direct F3
holding HQY Stock Option (right to buy) 8,024 15 Jul 2021 Common Stock 8,024 $66.06 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.77 to $76.70, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnote (1) and (2) of this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.91 to $77.20, inclusive.
F3 The option is immediately exercisable.

Remarks:

The Power of Attorney given by Mr. Sacks was previously filed with the U.S. Securities & Exchange Commission on February 3, 2017 as an exhibit to a statement on Form 4 filed by Mr. Sacks with respect to HealthEquity, Inc. and is hereby incorporated by reference.